Biosimilars

Manufacturer Solutions

Helping your newest products thrive

AmerisourceBergen’s integrated commercialization and distribution services help biosimilar manufacturers realize the potential of this new and unique class of therapy. Our collaborative experts can help you devise channel strategies and select tailored solutions that overcome barriers to access and uptake.

Reaching patients where they are

Our extensive reach into health systems, physician practices, pharmacies and alternate sites of care makes your product accessible to patients and providers throughout the healthcare continuum. And our best-in-class distribution network ensures that your product reaches the right patients at the right time.
Learn more
Our relationships span:
95%
U.S. HOSPITALS
65K+
SPECIALTY PHYSICIAN PRACTICES
34%
U.S. RETAIL PHARMACIES

Specialty physician GPO contracting

Connect with thousands of prescribers through our market-leading specialty and oncology GPOs, which comprise a collective purchasing power that is unrivaled in the industry. Members benefit from a versatile contract portfolio, clinically integrated specialty pharmacy services, practice management education and advocacy programs. Our integrated model tightens the provider-patient relationship and allows providers to more effectively guide treatment for better patient outcomes.
Visit ION Solutions Visit IPN

Improving product performance through targeted communication

Raise awareness of your newest product offerings through our CustomConnect℠ multi-channel marketing programs. CustomConnect seamlessly integrates your product message into customers' workflows so your communication stands out and gets recognized.

Contact us

Provider awareness and education

Understanding the complex coverage and payment
landscape is critical to the success of any practice and vital to the success of your biosimilar. Xcenda, part of AmerisourceBergen, can help you develop legally compliant education programs that increase providers’ understanding of your product. Our policy and reimbursement experts use their knowledge of the challenges providers and practice managers face to design and deliver engaging learning experiences.
Visit Xcenda
Nurse and Doctor consult at nurse's station

Field reimbursement support

Navigating reimbursement for new classes of therapies can pose a significant challenge for providers and patients alike. Our seasoned consultants anticipate reimbursement hurdles and create targeted strategies that maximize patient access at every stage of the product lifecycle. As your strategic partner, we can help you develop the coding and reimbursement tools necessary to minimize payment barriers for providers.
Visit Xcenda

Enhancing the patient experience

Navigating a serious health condition can be frustrating for any patient. Lash Group, part of AmerisourceBergen, offers support services that consistently and compassionately help patients overcome obstacles related to access, affordability and engagement—resulting in better treatment outcomes.

Increasing access

When a patient receives a life-changing diagnosis, the last thing they should have to worry about is fighting for the treatment they need. Our reimbursement services are instrumental in helping patients begin therapy more quickly and reducing patient drop-off once on therapy. Our dedicated counselors increase speed to therapy by working with payers to confirm coverage status, identifying potential barriers to access and coordinating with specialty pharmacies. 
Visit Lash Group

Improving affordability

We design programs that direct financial aid to uninsured and underinsured patients, following best practices developed from years of experience. Our range of patient assistance program (PAP) models,
distribution methods and processes are customizable to support your product and patient needs. Integrating seamlessly with our reimbursement and co-pay services, we help ensure that assistance funds are used effectively.
Visit Lash Group

Promoting engagement

Our adherence and engagement programs reduce patient drop-off by providing patients with the knowledge, resources and support they need to start and remain on therapy. From behavioral coaching and digital communication tools to product education, injection training and transportation assistance, our flexible solutions minimize barriers and help ensure that patients are equipped to continue their treatment journey. 
Visit Lash Group

International commercialization capabilities

Innomar Strategies, part of AmerisourceBergen, offers a range of integrated services for commercializing biosimilars in Canada. From market access consulting to patient support programs and distribution services, our experienced teams deliver customized, scalable solutions to successfully launch your product in the Canadian market.

Visit Innomar Strategies
Patient bedside care
Expert perspectives

Are biosimilars the new generics?

Dave Picard, Senior Vice President, Global Generic Pharmaceuticals at AmerisourceBergen, speaks with Becker's Hospital Review about the current state of the industry and upcoming trends for this new class of therapy.
Read the article

Featured Insights

AmerisourceBergen

Four Questions That Will Move Pharma Forward

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2017

Key themes from ThinkLive 2017, AmerisourceBergen's annual manufacturer summit.

AmerisourceBergen

The Growth of Biosimilars in the Oncology Pipeline

Dave Picard
September 2017

What should biosimilar manufacturers focus on for commercialization success?

AmerisourceBergen

Biosimilar Coding

Amanda Forys
August 2017

Alternative methodologies for coding biosimilars reveal an addition $15.1 billion in hidden savings.

Get in touch

Our integrated portfolio of solutions and decades of industry experience make us the right partner for your product's successful journey to commercialization. Start a conversation with us to see how we can provide the strategies you need for optimal product performance. 
Contact AmerisourceBergen